Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Conduit Pharmaceuticals Inc. - Common Stock (NQ:CDT)

3.320 -0.790 (-19.23%)
Streaming Delayed Price Updated: 12:52 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Conduit Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic
The company said that the reverse stock split will become effective on May 19 at 5:00 p.m. ET, and the stock will start trading on a reverse stock-split adjusted basis at market open on May 20. 
Via Stocktwits
Topics Government
Exposures Political
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
From Conduit Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
Conduit Pharmaceuticals Announces Leadership Changes
From Conduit Pharmaceuticals
Via GlobeNewswire
What's Going On With Conduit Pharmaceuticals Shares Friday?
Conduit shares are trading higher after the company announced it filed multiple patents related to VTAMA (tapinarof). 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
From Conduit Pharmaceuticals
Via GlobeNewswire
Wondering what's happening in today's after-hours session?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
Top stock movements in today's session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
From Conduit Pharmaceuticals
Via GlobeNewswire
Wondering what's happening in today's after-hours session?
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Progresses Phase II of its AI Initiative with Sarborg
From Conduit Pharmaceuticals
Via GlobeNewswire
Thursday's pre-market session: top gainers and losers
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
From Conduit Pharmaceuticals
Via GlobeNewswire
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
From Conduit Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Wondering what's happening in today's after-hours session?
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Top stock movements in today's session.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Dow Dips 400 Points; US Adds Fewer Than Expected Jobs
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS